Ampio Pharmaceuticals, Inc. (AMPE)
Long: Weak Open, Higher Low & R/G
Story: No News Here.
Thoughts: Just Play the technical's. It's been trending upwards.
CTPartners Executive Search Inc. (CTP)
Long: Weak Open & R/G
Short: Gap Up, Parabolic through $8.50 or $9... Risk off $10.. Starting in after $9..
Story: This is one dodgy company. They seem to be doing all sorts of wrong to their shareholders the past month, from offerings to missing guidance on preliminary earnings, and then withdrawing their 4Q and year end guidance 1 week after the release.They appointed a new CEO though.
Thoughts: The Story isn't very good, but the daily chart seems to have an Upside-down ABCD pattern. Only Play clean chart patterns on the long side.
Amicus Therapeutics, Inc. (FOLD)
Long: Weak Open, Higher Low.
Story: Reported Q4 loss last week.
Thoughts: I'm Seeing some sort of an ABCD type pattern on the daily chart and bullish trend where all the dips are getting bought up.
Geron Corporation (GERN)
Long: Weak Open & R/G
Story: Reported an Earnings Loss last week, the year/year loss is lower though.
Thoughts: This news is a week old now, so I feel it's almost 100% price action and technical play now. And the technicality's aren't looking great.
Horizon Pharma plc (HZNP)
Long: Buy any higher lows
Short: Any 50c+ parabolic move, Stop off whole and half dollar marks, entry order 400 shares, 4-5c below the whole or half dollar stop. The Parabolics seem to fall back to the previous whole or half dollar mark.
Story: Plans to use $350M from Offering to fund future acquisitions or investments in businesses or products. Released pre-clinical data showing improved signs disease severity of Rare Bone Disease.
Thoughts: Same thoughts as yesterday - "I still feel this can keep going but it's quite a choppy stock. Seems to look alright for shorting if you only wait for parabolic action and risk off whole and half dollar marks, keeping your total size small and your average within 5-10c of the whole and half dollar mark. Parabolic being a 50c+ spike." It could be going but at the same time, it's starting to go into overextended territory.
Synergy Pharmaceuticals, Inc. (SGYP)
Long: Weak Open, Higher Low & R/G
Story: No News
Thoughts: I'm not too excited about this one. But it seems to have a bullish trend where all the dips are getting bought up.
SIGA Technologies, Inc. (SIGA)
Long: Weak Open, Higher Low & R/G
Story: Released their 10-K (Annual Report) on Friday 6th of March, there wasn't an announcement until Sunday 8th..
Thoughts: I'm not sure if people liked the report or not because the following Monday Red (Last Monday), but it has had a technical breakout over $2.50 now... Could have some Resistance at $2.75 though.
Supernus Pharmaceuticals, Inc. (SUPN)
Long: Weak Open, Higher Low & R/G+$11.00 break.
Story: Earnings Winner
Thoughts: It's an Earnings Winner - so it can only be a buy. But, it's just floating up here, which gives room for some consolidation (In my opinion). I want a weak open and higher low because if this thing go over the R/G line, it will have $11.00 buyers as well. With no real resistance up to the $11.40's.
Solazyme, Inc. (SZYM)
Long: Weak Open + R/G
Story: Released their 10-K (Annual Report) and S-8 (Securities to be offered to employees in employee benefit plans) on the 6th March.
Thoughts: It looks like a trend change on the Daily Chart and I'd like a Weak Open and Red/Green play
Urban Outfitters Inc. (URBN)
Long: Weak Open + R/G or ABCD.. Either Way, You need Higher Lows for this one.
Story: Reported a profit yesterday but also beat estimates, which I guess it's really all about.
Thoughts: Don't really know why I put it down as a Short yesterday, maybe it would've given a nice reaction trade with a parabolic but it's still an Earnings Winner.
No comments:
Post a Comment